Market closed·Syncing…
SMEMarket closed · Close · 19 Nov

Avience Biomedicals Limited AVIENCEshare price and chart

Avience Biomedicals closed at ₹251.45 on 19 November 2026, up 4.99% on the day. The range since listing is ₹222.00 to ₹414.95.

₹251.45The price one share last traded at, in rupees.+4.99% · ₹11.95
Low since listing ₹22215% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹415

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on AVIENCE

Real prices, every charge counted. Pick one or write your own.
What Avience Biomedicals Limited does
A short, human-reviewed summary of the business, written from public sources. Background, not analysis, and not updated intraday.
business summary

Avience Biomedicals makes and supplies diagnostic products and medical devices, including viral transport media, COVID-19, HIV, hepatitis B, malaria and dengue test kits, serology products, and biochemistry analysers and reagents.

1
1Sector

Healthcare Equipment & Supplies

2
2What it sells

Diagnostic kits, serology products, biochemistry analysers and reagents

3
3Who buys it

Healthcare institutions and laboratories

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
46.8Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
65.5%Near average
today 65.5%20d avg 77.1%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.▼ 12.9%1 monthHow much the share price has changed over the period.▼ 1.0%3 monthsHow much the share price has changed over the period.+7.0%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.52.5%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹138 Cr19 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.12.2xlast 4 quarters, to Sept 2026Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.2.24xbooks of Sept 2026Return on capitalHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.23.2%full year FY26Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.44xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.-14.4%year to Mar 2026

Against its sectorWhere this company ranks among similar companies on each measure.

Medical Equipment & Supplies · 16 peers · medians
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.12.24vs 37 median
Cheapest: GKB 6.05Priciest: TARSONS 215.39
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.17.16%vs 4.31% median
Lowest: MHHL -4.14%Highest: AVIENCE 17.16%

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
64.59%promoter holding, as of 2026-09-30+0.0 pts since 2026
Promoter share since listing
2026-0664.59% now, drawn to its own range2026-09
Who owns it todayas of Sep 26
64.6%
31.9%
Promoter64.6%Domestic (DII)3.5%Public & others31.9%
Who is buying, who is leavingJun 26 to Sep 26
Promoter64.6%steady
Foreign (FII)0.0%-3.0 pts
Domestic (DII)3.5%-5.6 pts

Each line is that holder's share of all shares over the last 2 quarters, drawn to its own scale - the printed change is the size of the move. Mutual funds and insurers sit inside the domestic figure; hover the bar above for that split.

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Analysts/Institutional Investor Meet/Con. Call Updates19-Nov-2026

Avience Biomedicals Limited has informed the Exchange about Transcript

Analysts/Institutional Investor Meet/Con. Call Updates18-Nov-2026

Avience Biomedicals Limited has informed the Exchange about Link of Recording

Investor Presentation13-Nov-2026

Avience Biomedicals Limited has informed the Exchange about Investor Presentation

Analysts/Institutional Investor Meet/Con. Call Updates12-Nov-2026

Avience Biomedicals Limited has informed the Exchange about Schedule of meet

Outcome of Board Meeting10-Nov-2026

Avience Biomedicals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Certificate under SEBI (Depositories and Participants) Regulations, 201828-Oct-2026

Avience Biomedicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018: Reconciliation of Share Capital Audit Certificate Q 30 September, 2026

Certificate under SEBI (Depositories and Participants) Regulations, 201828-Oct-2026

Avience Biomedicals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter28-Oct-2026

Avience Biomedicals Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q 30 September, 2026 FY 2026-27

Analysts/Institutional Investor Meet/Con. Call Updates01-Oct-2026

Avience Biomedicals Limited has informed the Exchange about Outcome of Investor Conference

Shareholders meeting01-Oct-2026

Avience Biomedicals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.

Change in Auditors30-Sep-2026

Avience Biomedicals Limited has informed the Exchange regarding Change in Auditors of the company.

Shareholders meeting30-Sep-2026

Avience Biomedicals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026

Trading Window26-Sep-2026

Avience Biomedicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Analysts/Institutional Investor Meet/Con. Call Updates23-Sep-2026

Avience Biomedicals Limited has informed the Exchange about Schedule of meet

Updates16-Sep-2026

Avience Biomedicals Limited has informed the Exchange regarding 'Intimation of AGM, Book Closure and cutoff date for evtoing'.

Backtest idea · AVIENCEMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on AVIENCE
Backtest idea · AVIENCELower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on AVIENCE
Backtest idea · AVIENCESupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on AVIENCE
Your own ideaWrite a rule for AVIENCE in plain English“Buy AVIENCE when …”
Start writing
Buy the dip on AVIENCEBuy when RSI(14) drops below 30
52-week high breakout on AVIENCEBuy when closes at a 52-week high
Golden cross on AVIENCEBuy when 50-day EMA crosses above 200-day
Stochastic oversold on AVIENCEBuy when stochastic %K drops below 20
Pullback in an uptrend on AVIENCEBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹138 cr
Larger than 19% of 16 peers
sector middle ₹560 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
12.2x
Lower than 83% of 12 peers
sector middle 37.0x
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
2.2x
Lower than 64% of 14 peers
sector middle 2.4x
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.
23.2%
Higher than 92% of 12 peers
sector middle 11.4%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.44
Higher than 71% of 14 peers
sector middle 0.15
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 38% of 16 peers
sector middle 0.0%

Peers are the listed companies in the exchange's own industry group: Medical Equipment & Supplies. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.

Where the cash went

In FY26 cash fell by ₹2 Cr, after ₹13 Cr spent on plant and equipment.

FY26Cash in or out
Running the business+₹6 Cr
Investing-₹13 Cr
Lenders and shareholders+₹5 Cr
Net change in cash-₹2 Cr

The full numbersSales and net profit by financial year or by quarter.

Backtest idea · AVIENCEStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on AVIENCE
Backtest idea · AVIENCEPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on AVIENCE
Backtest idea · AVIENCEBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on AVIENCE
Backtest idea · AVIENCE52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on AVIENCE
Backtest idea · AVIENCEGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on AVIENCE
MACD momentum on AVIENCEBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on AVIENCEBuy when closes below the lower Bollinger band
Supertrend rider on AVIENCEBuy when supertrend turns up
Buy the dip on AVIENCEBuy when RSI(14) drops below 30
52-week high breakout on AVIENCEBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Medical Equipment & Supplies
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
MOLBIO
Molbio Diagnostics Limited
17,590 cr-12.2x--0.22--0.00%
POLYMED
Poly Medicure Limited
16,933 cr53.2x5.2x10.8%13.7%0.1214.8%+30.8%0.21%
TARSONS
Tarsons Products Limited
1,616 cr215.4x2.5x2.3%4.5%0.611.6%+20.8%0.00%
FISCHER
Fischer Medical Ventures Limited
1,496 cr87.9x3.2x8.1%11.5%0.114.3%+24.5%0.22%
LAXMIDENTL
Laxmi Dental Limited
1,060 cr32.7x4.0x12.8%13.1%0.0011.0%+10.0%0.00%
QLINE
Q-Line Biotech Limited
952 cr12.8x2.0x-19.5%0.2715.4%-0.00%
DENTALKART
Vasa Denticity Limited
840 cr69.7x4.4x-9.1%0.003.8%-0.00%
FABTECH
Fabtech Technologies Limited
593 cr15.7x1.4x9.1%11.3%0.079.2%-24.2%0.45%
OSELDEVICE
Osel Devices Limited
527 cr23.8x2.3x-23.9%0.649.5%-0.34%
QMSMEDI
QMS Medical Allied Services Limited
331 cr-3.6x--0.86--0.29%
NURECA
Nureca Limited
285 cr60.7x1.5x1.1%3.3%0.012.7%+55.1%0.00%
APRAMEYA
Aprameya Engineering Limited
238 cr-------0.00%
MADHAVBAUG
Vaidya Sane Ayurved Laboratories Limited
162 cr41.3x2.3x-16.9%0.183.4%+17.5%0.00%
AVIENCE
Avience Biomedicals Limited
138 cr12.2x2.2x-23.2%0.4417.2%-0.00%
MHHL
Mohini Health & Hygiene Limited
49 cr-0.5x--9.9%1.62-4.1%+50.2%0.00%
GKB
GKB Ophthalmics Limited
30 cr6.0x----3.2%+8.5%0.00%
GML
Galaxy Medicare Limited
26 cr8.7x0.6x-11.2%0.107.1%+7.8%4.15%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
·
·
·
·
·
·
-31.4
+3.8
+34.9
-29.6
-0.7
·
-32.9%
5m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2026-07-20SURESH ZUNZUNWALA · bulkSELL42,000₹265.55₹1.12 Cr
2026-07-20SURESH ZUNZUNWALA · bulkBUY42,000₹245.38₹1.03 Cr
2026-07-17SANDEEP KUMAR SAWARMAL HISARIA · bulkBUY1,00,200₹222.46₹2.23 Cr
2026-07-17SETU SECURITIES PVT LTD · bulkBUY70,200₹222.00₹1.56 Cr
2026-07-17MANSI SHARE AND STOCK BROKING PRIVATE LIMITED · bulkSELL65,400₹222.00₹1.45 Cr
2026-07-17SETU SECURITIES PVT LTD · bulkSELL56,400₹222.16₹1.25 Cr
2026-07-17NIRAJ RAJNIKANT SHAH · bulkSELL48,000₹222.05₹1.07 Cr
2026-07-17KASHMIRA AJAY PATEL · bulkSELL37,800₹240.99₹0.91 Cr

Read enough? Test AVIENCE. “Buy AVIENCE when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free